Healthcare utilization and costs of psychiatric and somatic comorbidities associated with newly diagnosed adult ADHD
Open accessThe DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
Background: Psychiatric and somatic problems in young adulthood have been found to be main drivers of costs in individuals with childhood ADHD. However, knowledge of the patterns of healthcare utilization and costs of comorbidities in middle‐aged adults with newly diagnosed ADHD is very limited. Method: We studied individuals born 1966–1978 (from the Swedish Total Population Register) with newly diagnosed ADHD between the ages of 30–45 years and individuals without ADHD matched on birthdate, birth county, and sex. Healthcare utilization and expenditure for psychiatric and somatic disorders were obtained over four years (two years pre‐ and post‐initial ADHD diagnosis). Results: Middle‐aged adults with newly diagnosed ADHD showed higher levels of healthcare utilization and costs (outpatient, inpatient, medications) for psychiatric and somatic comorbidities relative to adults without ADHD, both before and after the initial diagnosis. Females showed greater average group differences across the study period for medication prescriptions than males. Total incremental annual costs per capita were €2478.76 in adults with ADHD relative to those without, and costs were mainly driven by inpatient care. Psychiatric outpatient visits were statistically significantly higher the year before the ADHD diagnosis compared with two years before and after the diagnosis. Conclusion: This study demonstrates the substantial burden of psychiatric and somatic comorbidities in middle‐aged adults newly diagnosed with ADHD. Psychiatric outpatient visits peaked in the year leading up to the ADHD diagnosis. Findings further suggested that females with ADHD may seek more treatment for comorbidities than males, which may reflect a general female tendency.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Prevalence of DSM-IV Attention-Deficit/Hyperactivity Disorder: A Meta-Analytic Review
Willcutt, E. G. (2012) · Neurotherapeutics · doi:10.1007/s13311-012-0135-8 · Cited by 2,160
Wettermark, B., Hammar, N., MichaelFored, C., Leimanis, A., Otterblad Olausson, P., Bergman, U., Persson, I., Sundström, A., Westerholm, B., & Rosén, M. (2007) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1294 · Cited by 1,887
Attention-deficit/hyperactivity disorder
Faraone, S. V., Asherson, P., Banaschewski, T., Biederman, J., Buitelaar, J. K., Ramos-Quiroga, J. A., Rohde, L. A., Sonuga-Barke, E. J. S., Tannock, R., & Franke, B. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.20 · Cited by 1,479
Collaborators, O. B. O. T. W. W. M. H. S., Fayyad, J., Sampson, N. A., Hwang, I., Adamowski, T., Aguilar-Gaxiola, S., Al-Hamzawi, A., Andrade, L. H. S. G., Borges, G., de Girolamo, G., et al. (2017) · ADHD Attention Deficit and Hyperactivity Disorders · doi:10.1007/s12402-016-0208-3 · Cited by 824
Adult ADHD and comorbid disorders: clinical implications of a dimensional approach
Katzman, M. A., Bilkey, T. S., Chokka, P. R., Fallu, A., & Klassen, L. J. (2017) · BMC Psychiatry · doi:10.1186/s12888-017-1463-3 · Cited by 732 · cited 2×
“14,15 Furthermore, recent studies suggest that adult ADHD is still substantially underdiagnosed, and that comorbidities may lead to misdiagnoses or delayed diagnoses (ie, “diagnostic overshadowing”), which subsequently can delay appropriate treatment.”
Do men consult less than women? An analysis of routinely collected UK general practice data
Wang, Y., Hunt, K., Nazareth, I., Freemantle, N., & Petersen, I. (2013) · BMJ Open · doi:10.1136/bmjopen-2013-003320 · Cited by 622
Pharmacotherapy of Attention-deficit/Hyperactivity Disorder Reduces Risk for Substance Use Disorder
Biederman, J., Wilens, T., Mick, E., Spencer, T., & Faraone, S. V. (1999) · Pediatrics · doi:10.1542/peds.104.2.e20 · Cited by 493 · cited 1×
“17-19 It may be that early detection of adult ADHD would in turn improve the quality of life of those affected by preventing the development or at least reducing the severity of comorbidities 15,20,21 and may contribute to long-term cost savings for society.”
Chang, Z., Lichtenstein, P., D’Onofrio, B. M., Sjölander, A., & Larsson, H. (2014) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2013.4174 · Cited by 293
Self-citationGinsberg, Y., Quintero, J., Anand, E., Casillas, M., & Upadhyaya, H. P. (2014) · The Primary Care Companion For CNS Disorders · doi:10.4088/pcc.13r01600 · Cited by 274
Adult ADHD and Comorbid Somatic Disease: A Systematic Literature Review
Instanes, J. T., Klungsøyr, K., Halmøy, A., Fasmer, O. B., & Haavik, J. (2018) · Journal of Attention Disorders · doi:10.1177/1087054716669589 · Cited by 232
Cited by
Skoglund, C., Sundström Poromaa, I., Leksell, D., Ekholm Selling, K., Cars, T., Giacobini, M., Young, S., & Kopp Kallner, H. (2024) · Journal of Child Psychology and Psychiatry · doi:10.1111/jcpp.13920 · Cited by 77
Garcia-Argibay, M., Li, L., Du Rietz, E., Zhang, L., Yao, H., Jendle, J., Ramos-Quiroga, J. A., Ribasés, M., Chang, Z., Brikell, I., et al. (2023) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2023.105076 · Cited by 52
Self-citationGarcia-Argibay, M., Brikell, I., Thapar, A., Lichtenstein, P., Lundström, S., Demontis, D., & Larsson, H. (2024) · Biological Psychiatry · doi:10.1016/j.biopsych.2023.07.017 · Cited by 33
Self-citationMethylphenidate and short-term cardiovascular risk
Garcia-Argibay, M., Bürkner, P.-C., Lichtenstein, P., Zhang, L., D’Onofrio, B. M., Andell, P., Chang, Z., Cortese, S., & Larsson, H. (2024) · JAMA Network Open · doi:10.1001/jamanetworkopen.2024.1349 · Cited by 31
Self-citationGarcia‐Argibay, M., Du Rietz, E., Hartman, C. A., Lichtenstein, P., Chang, Z., Fava, C., Cortese, S., & Larsson, H. (2022) · International Journal of Methods in Psychiatric Research · doi:10.1002/mpr.1930 · Cited by 16
“…disorder, conduct disorder, antisocial personality disorder (in adults), substance use disorder (SUD), depressive disorder, and anxiety disorders, amongst others (Faraone et al., 2021; Garcia ‐ Argibay et al., 2022) leading into a substantial healthcare burden (Garcia ‐ Argibay et al., 2021).”
Self-citation
Metadata
- Authors
- Garcia‐Argibay, M., Pandya, E., Ahnemark, E., Werner‐Kiechle, T., Andersson, L. M., Larsson, H., & Du Rietz, E.
- Venue
- Acta Psychiatrica Scandinavica
- Publisher
- Wiley
- Published
- 2021-05-04
- Volume
- 144
- Issue
- 1
- Pages
- 50-59
- ISSN
- 0001-690X (ISSN-L)
- 1600-0447
- OpenAlex
- W3136567167
- Cited by
- 15
- References
- 16
- FWCI
- 1.59
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.